IR-MED signs LOI with Dice Technologies to advance PressureSafe pressure-injury prevention platform in Japan

• IR-MED signed a non-binding LOI with Japan’s Dice Technologies to evaluate and prepare commercialization of the PressureSafe device in Japan.
• Work covers clinical evaluation, localization, regulatory preparation with PMDA, integration into Dice’s CareNest platform and domestic EHR systems.
• Initial rollout targets long-term care facilities and home-visit settings to generate real-world utility data for a Japan launch.
• Clinical research is expected to involve Kobe University’s plastic surgery department, subject to ethics and institutional approvals.
• Japan focus reflects pressure-injury prevention demand across an aging population of 36.19 million people aged 65 and older.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. IR-MED Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202609160915PRIMZONEFULLFEED9828123) on September 16, 2026, and is solely responsible for the information contained therein.